How to read a COA

A discussion about the realities of the Canadian cannabis export market and the process of taking part within it. As the Canadian market continues to experience price compression, many producers are increasingly looking to markets like Australia, Europe, Israel, and South America. Is this an approach that makes sense for you, or another pipe dream? While prices may be higher, there can also be many challenges and dashed dreams. In this webinar, we speak with experts in the field to discuss both the process of getting approved for sale into foreign markets, as well as the realities of those markets. Panelists: Marjolène Alie (Senior Manager, Industrial Hemp and Import – Export Division, Controlled Substances and Cannabis Branch, Health Canada, Government of Canada) Brigitte Simons (CEO, Safari Flower and Director, C-45 Quality Association) Brandon Tate (President, BT Solutions and Director, C-45 Quality Association) Scott Mayer (CEO, Miracle Valley Medicinal Alternatives) Deepak Anand (Principal, ASDA Consultancy Services) Hosted by Tom Ulanowski, Chairperson, C-45 Quality Association

A presentation by Charlotte Peyton of EAS Consulting Group, on how to ensure quality systems for cannabis manufacturing with a focus on the US market. Hosted by: Tom Ulanowski, Chairperson, C-45 Quality Association

A critical exploration of cannabis product potency in Canada, this webinar delves into a landmark study spearheaded by Supra Research and Development's Rob O’Brien, along with seven other licensed analytical testing laboratories across Canada. The focus of this study was to objectively assess the THC levels in a variety of cannabis products – dried flower, non-infused and infused pre-rolls – available on the Canadian market. The study's findings highlight significant discrepancies between the THC levels claimed on product labels and the actual content determined through laboratory testing. This comprehensive analysis involved sampling 16 brands of 3.5 g dried flower products, 4 brands of non-infused pre-rolls, and 15 brands of infused pre-rolls. The research utilized a variance range similar to federal cannabis regulations: 25% for dried flower and pre-rolls, and a stricter 15% for infused pre-rolls. Astonishingly, over half of the dried flower samples were found to be more than 25% below their label claims, with some exceeding a 40% deficit. This webinar will present these striking results, underscoring the prevalent issue of THC inflation and label inconsistency in the Canadian cannabis industry. There will be a 30 minute Q&A with the panelists, so that attendees can learn more about the study methods and implications of these results. PANELISTS: Rob O'Brien - Supra RnD Hubert Marceau - PhytoChemia Andrien Rackov - RPC Thomas Fraleigh - Vivariant Denise Johnson - Pura Labs Hosted by Tom Ulanowski (Chairperson, C-45 Quality Association)